Tuesday, October 14, 2025
HomeIndustriesHealthcare

Healthcare

MaxCyte Signs Platform License with Curamys to Enable Cell & Gene Therapies for the Treatment

MaxCyte, Inc., a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics and to...

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Akebia Therapeutics, Inc., a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted one newly-hired employee options...

Natus Medical Incorporated to Acquire Micromed Holding SAS

Natus Medical Incorporated, a leading provider of medical device solutions focused on the screening, diagnosis and treatment of central nervous and sensory system disorders,...

JelloX Biotech Leads Research in 3D Cancer Pathology as NCI Explores Potential

JelloX Biotech is celebrating a robust year of research and product development milestones while showcasing the potential for 3D imaging and AI to be...

At CTAD 2022 Diadem Highlights How Its AlzoSure Predict Prognostic Blood Test for Alzheimer’s Disease

Diadem SpA, a company developing the first blood-based test for the early prediction of progression to Alzheimer's disease (AD), presented clinical data at the...
0FansLike
0FollowersFollow
spot_img

Hot Topics